PRESS RELEASE Solvay Press Releases

Solvay second quarter 2026 results

What happened
Based on Solvay Press Releases · Jul 29, 2026

Solvay reported lower Q2 2026 earnings due to a Middle East plant shutdown and weaker volumes, but confirmed full-year guidance and plans to restart the facility in Q3.

🚩 Report a correction ↗ Open source
Solvay second quarter 2026 results
Solvay Press Releases — Solvay
Key points
·
The conflict in the Middle East had a negative impact on its performance, mainly due to the temporary shutdown since mid-March of its Peroxides plant in the region.
·
Despite these headwinds, its teams remain focused on the transformation of its company and the tangible progress in its safety performance shows that its transformation is delivering results.
·
We take the necessary actions to improve its operations and deliver on its guidance, while looking at opportunities to reinforce and expand its most promising activities in the future.
·
Maintaining strong cash discipline remains another clear priority.
Key numbers
·
Solvay’s second quarter 2026 results showed a decline in underlying net sales to €1,031 million, down 6.
·
4% year-on-year, primarily due to lower volumes in Peroxides and Special Chem.
·
The temporary shutdown of the Peroxides plant in Jubail, Saudi Arabia, following regional conflict, reduced output by approximately €20 million in EBITDA.

Solvay’s second quarter 2026 results showed a decline in underlying net sales to €1,031 million, down 6.4% year-on-year, primarily due to lower volumes in Peroxides and Special Chem. The temporary shutdown of the Peroxides plant in Jubail, Saudi Arabia, following regional conflict, reduced output by approximately €20 million in EBITDA. Despite these challenges, the company maintained stable pricing across most businesses, with soda ash seaborne markets experiencing slight declines.

Underlying EBITDA for the quarter fell 18.8% to €187 million, with the Middle East conflict accounting for roughly half of the decline. Fixed costs contributed positively through operational savings, offsetting inflation. Free cash flow to shareholders was negative €11 million in Q2, impacted by capital expenditures and working capital changes, though H1 2026 saw a positive €15 million. The company’s net financial debt rose to €1.8 billion, driven by dividend payments.

Solvay reaffirmed its full-year 2026 guidance, targeting underlying EBITDA between €770 million and €850 million, despite a €20 million negative currency impact and €40 million in transformation expenses. Free cash flow from continuing operations is expected to reach at least €200 million, with capital expenditures around €300 million. The company also aims for cumulative structural cost savings of €300 million by year-end, maintaining strong cash discipline as a priority.

The company announced strategic investments of €15-20 million to expand rare earth separation capacities at its La Rochelle facility in France, supported by new customer commitments. A Letter of Intent with Viridis secures rare earth supply from Brazil, reinforcing Solvay’s position in Europe’s rare earth separation market. Industrial-scale separation of dysprosium and terbium is set to begin in autumn 2026, further strengthening its capabilities in critical rare earth elements.

Original source → Deals on Clipraptor.com →